APA (7th ed.) Citation

T, M., YH, P., D, S., K, Y., E, H., SB, K., . . . PM, L. (2024). Author Correction: Inhibition of lysine acetyltransferase KAT6 in ER+HER2- metastatic breast cancer: a phase 1 trial. Nature medicine, 30(8), 2371. https://doi.org/10.1038/s41591-024-03129-w

Chicago Style (17th ed.) Citation

T, Mukohara, et al. "Author Correction: Inhibition of Lysine Acetyltransferase KAT6 in ER+HER2- Metastatic Breast Cancer: A Phase 1 Trial." Nature Medicine 30, no. 8 (2024): 2371. https://doi.org/10.1038/s41591-024-03129-w.

MLA (9th ed.) Citation

T, Mukohara, et al. "Author Correction: Inhibition of Lysine Acetyltransferase KAT6 in ER+HER2- Metastatic Breast Cancer: A Phase 1 Trial." Nature Medicine, vol. 30, no. 8, 2024, p. 2371, https://doi.org/10.1038/s41591-024-03129-w.